Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial

Facial seborrheic dermatitis (SD) is an inflammatory skin disease characterized by erythematous and scaly lesions on the skin with high sebaceous gland activity. The yeast Malassezia is regarded as a key pathogenic driver in this disease, but increased Staphylococcus abundances and barrier dysfuncti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousel, Jannik, Saghari, Mahdi, Pagan, Lisa, Nădăban, Andreea, Gambrah, Tom, Theelen, Bart, de Kam, Marieke L., Haakman, Jorine, van der Wall, Hein E. C., Feiss, Gary L., Niemeyer-van der Kolk, Tessa, Burggraaf, Jacobus, Bouwstra, Joke A., Rissmann, Robert, van Doorn, Martijn B. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531869/
https://www.ncbi.nlm.nih.gov/pubmed/37762625
http://dx.doi.org/10.3390/ijms241814315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531869/
https://www.ncbi.nlm.nih.gov/pubmed/37762625
http://dx.doi.org/10.3390/ijms241814315

Ejemplares similares